Connect Biopharma Holdings Ltd (CNTB) — Long-term Investment Intensity
Connect Biopharma Holdings Ltd (CNTB) has a Long-term Investment Intensity of 5.4% as of December 2022. Long-term investments of $65.74 Million represent 5.4% of total assets of $1.21 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See what is Connect Biopharma Holdings Ltd's book value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Connect Biopharma Holdings Ltd Long-term Investment Intensity (2022–2022)
This chart shows how Connect Biopharma Holdings Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2022 to 2022. As of December 2022, the intensity stands at 5.4%, reflecting long-term investments of $65.74 Million against total assets of $1.21 Billion USD. Also explore how large is Connect Biopharma Holdings Ltd's balance sheet for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Connect Biopharma Holdings Ltd (2022–2022)
The table below presents the year-by-year Long-term Investment Intensity for Connect Biopharma Holdings Ltd from 2022 to 2022, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Connect Biopharma Holdings Ltd worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 37.8% | $65.74 Million | $174.01 Million | — |